ORM1 and cancer: The results indicated that ORM1 was significantly downregulated in the hepatic cancer cells compared with the levels in non-cancerous cells; however, it was upregulated in microvascular invasion samples, especially in the cancer embolus, compared with that in the surrounding tumor cells.